MedPath

comparing the effectiveness of a drug with and without additives in post-operative pain relief among patients undergoing hip and lowerlimb surgeries

Not Applicable
Conditions
Health Condition 1: M968- Other intraoperative and postprocedural complications and disorders of musculoskeletal system, not elsewhere classifiedHealth Condition 2: M970- Periprosthetic fracture around internal prosthetic hip joint
Registration Number
CTRI/2024/02/062313
Lead Sponsor
Saveetha medical college and hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)Patients undergoing Dynamic hip screw fixation, Total hip replacement & Proximal femoral nailing

2)ASA I & II patients

Exclusion Criteria

1)Patient refusal

2)Critically ill patients (ASA III & above)

3)Evidence of coagulopathy

4)Infection at the site of puncture

5)Pregnant patients

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The duration of post-operative analgesia between 0.25% ropivacaine, ropivacaine with dexmedetomidine, and ropivacaine with dexamethasone will be assessed and compared using VAS score post operatively <br/ ><br> <br/ ><br>Timepoint: VAS score during the post-operative period at 2 hours,6 hours,12 hours,24 hours.
Secondary Outcome Measures
NameTimeMethod
The time of requirement of rescue analgesia between the three groups will be assessed & comparedTimepoint: Time of rescue analgesia in hours assessed at 2hours, 6 hours, 12 hours & 24 hours post operatively
© Copyright 2025. All Rights Reserved by MedPath